Why IVF Clinics Outgrow Generic EHRs Fast
Picture a single IVF cycle at a fertility clinic. One patient’s treatment touches reception scheduling, a physician’s clinical notes, a lab technician logging an egg retrieval, an embryologist grading and freezing embryos, and a billing team splitting the cost across insurance (if there’s any fertility coverage at all), a cash-pay treatment package, and sometimes a third-party fertility financing loan - all for one cycle, often repeated multiple times for the same patient. A generic EHR or practice-management system can schedule the appointment and send the invoice. It has no idea the lab work and the billing are supposed to be the same record.
Why doesn’t a standard medical EHR work here?
Because fertility care isn’t built around visits, it’s built around cycles - a sequence of monitoring appointments, procedures, and lab events that all have to stay linked to one treatment episode, with embryology data (grading, freezing, thawing, storage location) that a general EHR has no schema for. Clinics end up running the embryology lab on a separate system, or on paper, which means chain-of-custody documentation for a patient’s embryos - who handled them, when, under what conditions - lives outside the record that’s supposed to be the source of truth. That’s not a minor workflow gap; it’s the same category of financial and liability exposure vendors already sell against in ambulatory surgery centers tracking high-cost implants - a single mishandled high-value item, chain-of-custody failure, or billing error that the clinic absorbs directly.
Who actually owns this pain, and what do they care about?
It’s usually the practice administrator or lab director at an independent reproductive endocrinology (REI) practice - not a hospital system with a dedicated informatics team, but a clinic competing against larger fertility networks on patient experience and cost transparency. They’re personally accountable for two failure modes that generic software doesn’t prevent: a billing split that doesn’t match what was actually authorized across insurance, package pricing, and financing, and a lab error that no general EHR would even flag as a risk. A vendor who shows up only talking about appointment scheduling and patient portals hasn’t shown they understand either one.
What does outbound actually need to reference to land?
Three things, specifically: cycle-based billing that can split costs across multiple payers and funding sources without manual reconciliation; embryology workflow support with barcode or RFID-based specimen tracking and a documented chain of custody for creation, freezing, and storage; and integration between the clinical and lab side so a single cycle record doesn’t live in two disconnected systems. Mentioning these by name in a first message signals a vendor has actually talked to someone who runs a fertility clinic, not just a healthcare software vendor working from a generic ICP list.
Where does this buyer overlap with the broader healthcare & life sciences market Fypion already works in?
Independent fertility clinics sit in the same regulatory-aware, clinically-led buying motion as the rest of life sciences - a purchase has to clear clinical and operational scrutiny before it reaches a budget conversation - but they’re small enough that outreach built for hospital systems or diagnostic chains reads as obviously off-target. The opportunity is treating them as their own buyer, not a rounding error inside “healthcare software.”
Talk to us if your outbound to fertility clinics still reads like generic medical practice software instead of speaking to a cycle-based billing and embryology chain-of-custody problem they live with daily.